Stem cell growth factor shows promise as Alzheimer's treatment

07/2/2009 | New Kerala (India)

A U.S. study on Alzheimer's disease mice models found that injections of the granulocyte-colony stimulating factor -- a human growth factor used to trigger blood stem cell production in the bone marrow -- reduced the levels of beta amyloid protein that is considered a hallmark of the disease, as well as increased neuron production and promoted nerve-cell connections. The results indicate that the growth factor shows promise as a treatment "that may actually reverse disease, not just alleviate symptoms like currently available drugs," the lead author said.

View Full Article in:

New Kerala (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC